DNB Carnegie Access: Spago Nanomedical - Betydande framsteg i Tumorad-projektet
Idag, 10:00
DNB Carnegie intervjuar vd Mats Hansen för en genomgång av utvecklingen inom Tumorad, där fas I-studien nu närmar sig sitt slutförande. Vi diskuterar de resultat som hittills noterats samt den fortsatta vägen framåt för projektet.
Se intervjun här: https://youtu.be/kh8-Vg4PSR0
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://access.dnbcarnegie.com/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
DNB Carnegie Access: Spago Nanomedical - Betydande framsteg i Tumorad-projektet
Idag, 10:00
DNB Carnegie intervjuar vd Mats Hansen för en genomgång av utvecklingen inom Tumorad, där fas I-studien nu närmar sig sitt slutförande. Vi diskuterar de resultat som hittills noterats samt den fortsatta vägen framåt för projektet.
Se intervjun här: https://youtu.be/kh8-Vg4PSR0
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://access.dnbcarnegie.com/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
Analys
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
